Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?

Oruka Therapeutics Ownership Summary

Oruka Therapeutics is owned by 114.39% institutional investors, 1.36% insiders. Fmr is the largest institutional shareholder, holding 16.29% of ORKA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Oruka Therapeutics shares.

ORKA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oruka Therapeutics	114.39%	1.36%	-15.75%
Sector	Healthcare Stocks	35.75%	11.89%	52.37%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	7.43M	16.29%	$364.51M
Vr adviser	4.15M	9.09%	$203.48M
Fairmount funds management	3.71M	8.12%	$181.74M
Blackrock funding, inc. /de	3.53M	7.73%	$173.00M
Viking global investors lp	2.67M	5.85%	$130.80M
Vanguard group	2.45M	5.57%	$74.37M
Paradigm biocapital advisors lp	2.32M	5.09%	$113.81M
Rtw investments, lp	2.06M	4.51%	$100.95M
Deep track capital, lp	2.03M	4.46%	$99.78M
State street	1.61M	3.54%	$79.14M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fairmount funds management	3.71M	13.13%	$181.74M
Avidity partners management lp	760.42K	11.77%	$52.02M
Vr adviser	4.15M	7.59%	$203.48M
Cable car capital	200.00K	3.39%	$9.81M
B group	75.00K	2.73%	$3.68M
Synergy asset management	476.20K	2.48%	$23.36M
Paradigm biocapital advisors lp	2.32M	2.33%	$113.81M
Sr one capital management, lp	430.33K	2.31%	$21.11M
Superstring capital management lp	63.59K	2.23%	$3.12M
Great point partners	183.33K	2.07%	$8.99M

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	2.45M	0.00%	676.87K
Paradigm biocapital advisors lp	2.32M	2.33%	610.00K
Bellevue group	507.01K	0.59%	507.01K
Westfield capital management co lp	313.13K	0.06%	313.13K
Citadel advisors	1.01M	0.01%	281.42K

Top Sellers

Holder	Shares	% Assets	Change
Commodore capital lp	-	-	-1.75M
Avoro capital advisors	-	-	-1.33M
Blackstone	-	-	-1.17M
Point72 asset management	-	-	-600.00K
Frazier life sciences management	-	-	-583.33K

New Positions

Holder	Shares	% Assets	Change	Value
Bellevue group	507.01K	0.59%	507.01K	$24.87M
Westfield capital management co lp	313.13K	0.06%	313.13K	$15.36M
Vanguard fiduciary trust	257.07K	0.00%	257.07K	$12.61M
Ikarian capital	242.02K	0.96%	242.02K	$11.87M
Atika capital management	229.90K	1.42%	229.90K	$11.28M

Sold Out

Holder	Change
Sbi securities	-6.00
Aster capital management (difc)	-25.00
Rise advisors	-36.00
Srs capital advisors	-72.00
Daiwa securities group	-116.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	182	26.39%	52,177,550	-1.28%	114	0.80%	125	25.00%	30	87.50%
Dec 31, 2025	62	-43.12%	11,958,114	-73.75%	27	0.23%	45	-28.57%	4	-82.61%
Sep 30, 2025	42	-48.15%	6,253,192	-81.84%	14	0.22%	25	-51.92%	9	-35.71%
Jun 30, 2025	80	17.65%	34,421,525	22.70%	81	1.80%	53	20.45%	14	27.27%
Mar 31, 2025	70	7.69%	31,776,535	2.46%	76	1.28%	44	-8.33%	11	37.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.72M	2.85%	341.21K
Fidelity Growth Compy Commingled Pl S	1.62M	2.68%	968.60K
Polar Capital Biotech S Inc	1.23M	2.03%	236.44K
Fidelity Growth Company Fund	1.20M	1.99%	724.37K
iShares Russell 2000 ETF	1.11M	1.84%	10.24K
State Street® SPDR® S&P® Biotech ETF	842.04K	1.40%	-5.17K
Fidelity Select Health Care	831.70K	1.38%	-179.91K
Fidelity Advisor Biotechnology I	737.39K	1.22%	26.60K
Fidelity Select Biotechnology	562.68K	0.93%	86.90K
Fidelity Small Cap Growth	553.41K	0.92%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 01, 2026	Fairmount Funds Management LLC		Sell	$300.01M
Jul 01, 2026	Sandler Laura Lee	Chief Operating Officer	Sell	$209.93K
Jul 01, 2026	Sandler Laura Lee	Chief Operating Officer	Sell	$47.74K
Jul 01, 2026	Sandler Laura Lee	Chief Operating Officer	Sell	$214.41K
Jun 22, 2026	Agarwal Arjun	Senior Vice President, Finance	Sell	$57.42K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	4
2026 Q2	-	34
2026 Q1	-	17
2025 Q4	-	4
2025 Q3	-	-

ORKA Ownership FAQ

Who Owns Oruka Therapeutics?

Oruka Therapeutics shareholders are primarily institutional investors at 114.39%, followed by 1.36% insiders and -15.75% retail investors. The average institutional ownership in Oruka Therapeutics's industry, Biotech Stocks , is 36.05%, which Oruka Therapeutics exceeds.

Who owns the most shares of Oruka Therapeutics?

Oruka Therapeutics’s largest shareholders are Fmr (7.43M shares, 16.29%), Vr adviser (4.15M shares, 9.09%), and Fairmount funds management (3.71M shares, 8.12%). Together, they hold 33.51% of Oruka Therapeutics’s total shares outstanding.

Does Blackrock own Oruka Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Oruka Therapeutics.

Who is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested, with 13.13% of its assets in 3.71M Oruka Therapeutics shares, valued at 181.74M$.

Who is the top mutual fund holder of Oruka Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Oruka Therapeutics shares, with 2.85% of its total shares outstanding invested in 1.72M Oruka Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools